Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong Th17/Th1 T-cell responses
- 31 March 2011
- journal article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 127 (3), 787-794.e9
- https://doi.org/10.1016/j.jaci.2010.12.009
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A Subpopulation of CD163-Positive Macrophages Is Classically Activated in PsoriasisJournal of Investigative Dermatology, 2010
- Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8The Journal of Experimental Medicine, 2009
- Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient miceJCI Insight, 2009
- Resident and “Inflammatory” Dendritic Cells in Human SkinJournal of Investigative Dermatology, 2009
- Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cellsEuropean Journal of Immunology, 2009
- Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myelomaBlood, 2008
- Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responsesThe Journal of Experimental Medicine, 2007
- CXCL12-CXCR4 Engagement Is Required for Migration of Cutaneous Dendritic CellsThe American Journal of Pathology, 2007
- Phenotypic and functional features of human Th17 cellsThe Journal of Experimental Medicine, 2007
- IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesisThe Journal of Experimental Medicine, 2006